OK dall’Antitrust Europeo per Teva-ratiopharm
ago 04
Press Release
Teva Receives European Commission Approval for ratiopharm Acquisition
Jerusalem, Israel, August 3, 2010 – Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the Company received approval from the European Commission to proceed with its acquisition of ratiopharm. In connection with this approval and following the Commission’s review of this transaction, Teva made certain limited commitments, which are anticipated to have only a marginal effect on the combined companies’ activities. Teva now plans to close the transaction in the near future.
